What is the value of outcomes research?
By Kevin Frick (kevin.frick@rxcomms.com) It is ironic that we should have to answer the question: “what is the value of outcomes research?” when outcomes research is a key component of…
Sorting out the varying standards for pharmacoeconomic guidelines
By Kevin Frick (kevin.frick@rxcomms.com) As we provide and interpret pharmacoeconomic (PE) evaluation results for decision makers in different settings around the world, we should consider the standards being followed. And…
Health economists’ broader role in lifestyles, demographics, and risk management
Many economists think their profession has something to say about almost everything. This is because nearly everything can be thought of in terms of incentives and constraints.
How health economists can develop a global perspective
Health economists interacting with colleagues and clients often need to have a global perspective, which means not limiting one’s view to what is going on in one’s own country… and that goes beyond economics.
Book review: Methods for the economic evaluation of health care programmes – 3rd edition
Edited by Michael F. Drummond, Mark J. Sculpher, George W. Torrance, Bernie J. O’Brien, and Greg L. Stoddart. Oxford University Press, 2005, $55/£29.50, 379 pages. Reviewed by Kevin D. Frick…
Book review: Prevention effectiveness – 2nd edition
Edited by Anne Haddix, Steven Tuesch, and Phaedra Corso, Oxford University Press, 2002, US$45, £26.99, 286 pages. Reviewed by Kevin D. Frick This text is required reading for students…
Finding those journals with a positive interest in health economics
By Amy Rothman Schonfeld Print journals remain one of the most credible sources for disseminating health economic research findings, and there is consensus about which are the core publications for…